- Home
- TRML vs EOSE Comparison
TRML vs EOSE Comparison
Compare TRML & EOSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRML
- EOSE
- Stock Information
- Founded
- TRML 2021
- EOSE 2008
- Country
- TRML United States
- EOSE United States
- Employees
- TRML N/A
- EOSE N/A
- Industry
- TRML Biotechnology: Pharmaceutical Preparations
- EOSE Industrial Machinery/Components
- Sector
- TRML Health Care
- EOSE Miscellaneous
- Exchange
- TRML Nasdaq
- EOSE Nasdaq
- Market Cap
- TRML 509.8M
- EOSE 542.2M
- IPO Year
- TRML N/A
- EOSE N/A
- Fundamental
- Price
- TRML $12.21
- EOSE $4.48
- Analyst Decision
- TRML Strong Buy
- EOSE Buy
- Analyst Count
- TRML 6
- EOSE 6
- Target Price
- TRML $54.00
- EOSE $5.58
- AVG Volume (30 Days)
- TRML 344.8K
- EOSE 6.7M
- Earning Date
- TRML 03-18-2025
- EOSE 03-04-2025
- Dividend Yield
- TRML N/A
- EOSE N/A
- EPS Growth
- TRML N/A
- EOSE N/A
- EPS
- TRML N/A
- EOSE N/A
- Revenue
- TRML N/A
- EOSE $14,963,000.00
- Revenue This Year
- TRML N/A
- EOSE N/A
- Revenue Next Year
- TRML N/A
- EOSE $1,044.55
- P/E Ratio
- TRML N/A
- EOSE N/A
- Revenue Growth
- TRML N/A
- EOSE 20.34
- 52 Week Low
- TRML $12.12
- EOSE $0.61
- 52 Week High
- TRML $48.31
- EOSE $6.64
- Technical
- Relative Strength Index (RSI)
- TRML 25.27
- EOSE 38.63
- Support Level
- TRML $12.13
- EOSE $4.38
- Resistance Level
- TRML $14.58
- EOSE $5.11
- Average True Range (ATR)
- TRML 0.84
- EOSE 0.46
- MACD
- TRML -0.05
- EOSE -0.14
- Stochastic Oscillator
- TRML 1.79
- EOSE 5.76
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.
About EOSE Eos Energy Enterprises Inc.
Eos Energy Enterprises Inc designs develop, manufactures, and markets zinc-based energy storage solutions for utility-scale, microgrid, and commercial & industrial (C&I) applications. The solutions are used in the utility sector, the renewable energy sector, and the industrial sector. It's flagship product Eos Znyth is a stationary battery energy storage system.